31466-44-1,
2-Morpholin-4-yl-2-phenylethylamine,
2-Morpholin-4-yl-2-phenyl-ethylamine,
2-Morpholino-2-phenylethanamine,
2-(Morpholin-4-Yl)-2-Phenylethan-1-Amine,
2-morpholin-4-yl-2-phenylethanamine,
4-Morpholineethanamine, beta-phenyl-,
2-(morpholin-4-yl)-2-phenylethanamine,
ZERO/005325,
AC1MKKCX,
AC1Q53NO,
AC1Q53NP,
TimTec1_008424,
SCHEMBL856294,
CTK4G7178,
DCA-0-0,
DTXSID10390161,
WSNSRJWLIVDXDI-UHFFFAOYSA-N,
4-Morpholineethanamine,|A-phenyl-,
HMS1557O20,
ALBB-000169,
2-Morpholin4-yl-2-phenyl-ethylamine,
9971AD,
AR3497,
MFCD01631944,
SBB010173,
STK350731,
2-(4-morpholinyl)-2-phenylethanamine,
2-(4-morpholinyl)-2-phenylethylamine,
AKOS000153138,
AKOS016040424,
MCULE-4753881148,
NCGC00374337-01,
BAS 09615087,
BS-14019,
SC-40629,
AB0087021,
ST4119551,
TR-013380,
BB 0218531,
FT-0678370,
EN300-30489,
Z-0883,
2 - Morpholin - 4 - yl - 2 - phenylethylamine,
I05-2487,
Z1262396053,
C12H18N2O,
CID3158583,